據悉微軟正在擴大OpenAI軟件ChatGPT的取用渠道
格隆匯1月17日丨據市場消息,微軟(MSFT.US)正在擴大OpenAI軟件ChatGPT的取用渠道,而OpenAI是微軟支持的一家創業公司,其在去年11月發佈的ChatGPT聊天機器人大受歡迎,風靡硅谷。微軟表示,其Azure OpenAI服務的用户,現在可以預覽ChatGPT,此項技術現已普遍可用,預計使用量將大增。知情人士稱,微軟已考慮在2019年時宣佈持有10億美元OpenAI股份的基礎上加碼投資;據悉,投資金額可能達100億美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.